Can eye surgery work for HIV patients in africa? new study aims to find out

NCT ID NCT04704648

Recruiting now Knowledge-focused Sponsor: AIDS Malignancy Consortium Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether it's practical to surgically remove a type of eye surface tumor (OSSN) in people living with HIV in Sub-Saharan Africa. About 84 participants will have the tumor cut out and be followed for a year to see if the procedure is safe and if patients return for check-ups. The goal is to gather information to plan larger future studies, not to prove the surgery cures or controls the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: surgical excision
What this could lead to: If successful, this could pave the way for larger studies to improve treatment of eye surface tumors in people with HIV in Africa.
What could go wrong: This is a small feasibility study, not designed to prove the surgery works. It may not show clear benefits or be generalizable to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease human papilloma virus infection ocular surface squamous neoplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV OCULAR SURFACE SQUAMOUS NEOPLASIA

Contacts and locations

Locations

Uganda Cancer Institute
RECRUITING

Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.